Flavin Financial Services Inc. Decreases Stake in Kenvue Inc. $KVUE

Flavin Financial Services Inc. reduced its stake in shares of Kenvue Inc. (NYSE:KVUE) by 2.5% during the 2nd quarter, Holdings Channel.com reports. The firm owned 48,058 shares of the company’s stock after selling 1,229 shares during the period. Flavin Financial Services Inc.’s holdings in Kenvue were worth $1,006,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in the stock. Evergreen Wealth Solutions LLC boosted its position in shares of Kenvue by 2.6% during the 1st quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company’s stock worth $402,000 after purchasing an additional 432 shares in the last quarter. Scott & Selber Inc. boosted its position in shares of Kenvue by 0.4% during the 1st quarter. Scott & Selber Inc. now owns 106,621 shares of the company’s stock worth $2,557,000 after purchasing an additional 475 shares in the last quarter. Wealth Alliance LLC boosted its position in shares of Kenvue by 1.6% during the 1st quarter. Wealth Alliance LLC now owns 31,778 shares of the company’s stock worth $762,000 after purchasing an additional 486 shares in the last quarter. Everett Harris & Co. CA boosted its position in shares of Kenvue by 1.4% during the 1st quarter. Everett Harris & Co. CA now owns 36,971 shares of the company’s stock worth $887,000 after purchasing an additional 500 shares in the last quarter. Finally, Proffitt & Goodson Inc. boosted its position in shares of Kenvue by 8.2% in the 2nd quarter. Proffitt & Goodson Inc. now owns 6,831 shares of the company’s stock worth $143,000 after buying an additional 517 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

KVUE has been the topic of several recent research reports. UBS Group decreased their price objective on shares of Kenvue from $23.00 to $17.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. Citigroup decreased their price objective on shares of Kenvue from $20.00 to $17.00 and set a “neutral” rating on the stock in a research report on Thursday, October 9th. Rothschild Redb upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 26th. Redburn Partners set a $22.00 price objective on shares of Kenvue in a research report on Friday, September 26th. Finally, Evercore ISI decreased their price objective on shares of Kenvue from $23.00 to $18.00 and set an “in-line” rating on the stock in a research report on Tuesday, September 23rd. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Kenvue has an average rating of “Hold” and a consensus target price of $21.18.

Kenvue Trading Up 8.4%

Shares of KVUE stock opened at $15.30 on Friday. The firm has a 50-day moving average price of $18.54 and a 200 day moving average price of $21.04. Kenvue Inc. has a twelve month low of $14.05 and a twelve month high of $25.17. The company has a market capitalization of $29.37 billion, a price-to-earnings ratio of 20.68, a PEG ratio of 2.20 and a beta of 0.72. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.01. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The firm had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the previous year, the company posted $0.32 EPS. The firm’s revenue for the quarter was down 4.0% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th were paid a $0.2075 dividend. This represents a $0.83 annualized dividend and a yield of 5.4%. The ex-dividend date of this dividend was Wednesday, August 13th. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. Kenvue’s dividend payout ratio is presently 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.